Cargando…
AL amyloidosis: advances in diagnosis and management
Light chain (AL) amyloidosis is a disease in which malignant plasma cell clones affect multiple organs including the heart and kidney. The mechanism for organ function deterioration in AL amyloidosis differs from multiple myeloma. Thus, not all agents used to treat multiple myeloma shows similar eff...
Autor principal: | Koh, Youngil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386888/ https://www.ncbi.nlm.nih.gov/pubmed/32719177 http://dx.doi.org/10.5045/br.2020.S009 |
Ejemplares similares
-
Light chain (AL) amyloidosis: update on diagnosis and management
por: Rosenzweig, Michael, et al.
Publicado: (2011) -
Systemic AL Amyloidosis: Current Approaches to Diagnosis and Management
por: Fotiou, Despina, et al.
Publicado: (2020) -
AL Amyloidosis for the Cardiologist and Oncologist: Epidemiology, Diagnosis, and Management
por: Witteles, Ronald M., et al.
Publicado: (2019) -
Current Updates on the Management of AL Amyloidosis
por: Elsayed, Marwa, et al.
Publicado: (2021) -
The Amyloidosis Forum: a public private partnership to advance drug development in AL amyloidosis
por: Lousada, Isabelle
Publicado: (2020)